Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bedane

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Annales De Dermatologie Et De Venereologie|March 31, 2005
[Bullous pemphigoid in young patients: a retrospective study of 74 cases]E Bourdon-Lanoy, J-C Roujeau, P Joly, et al.
Neuro-Chirurgie|September 22, 2014
[Locoregional treatments of brain metastases for patients with metastatic cutaneous melanoma: French national guidelines]V Lubrano, S Derrey, G Truc, et al.
Dermatology (Basel, Switzerland)|January 20, 2004
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient seraP Joly, Ph Courville, C Lok, et al.
The British Journal of Dermatology|June 26, 2021
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg<sup>-1</sup> per day starting dose of oral corticosteroids to treat bullous pemphigoidV Hébert, S Bastos, K Drenovska, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized studyT Jouary, C Leyral, B Dreno, et al.
Annales De Dermatologie Et De Venereologie|July 20, 2004
[Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies]A Gary, P Carvalho, J-B Louison, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2023
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life studyK Khelef, E Maubec, G Jeudy, et al.
Annales De Dermatologie Et De Venereologie|April 2, 2019
[Update of the French recommendations for the management of pemphigus]L Jelti, C Prost-Squarcioni, S Ingen-Housz-Oro, et al.
The British Journal of Dermatology|September 6, 2019
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effectD M Chen, A Odueyungbo, E Csinady, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Annales De Dermatologie Et De Venereologie|March 31, 2005
[Bullous pemphigoid in young patients: a retrospective study of 74 cases]E Bourdon-Lanoy, J-C Roujeau, P Joly, et al.
Neuro-Chirurgie|September 22, 2014
[Locoregional treatments of brain metastases for patients with metastatic cutaneous melanoma: French national guidelines]V Lubrano, S Derrey, G Truc, et al.
Dermatology (Basel, Switzerland)|January 20, 2004
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient seraP Joly, Ph Courville, C Lok, et al.
The British Journal of Dermatology|June 26, 2021
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg<sup>-1</sup> per day starting dose of oral corticosteroids to treat bullous pemphigoidV Hébert, S Bastos, K Drenovska, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2011
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized studyT Jouary, C Leyral, B Dreno, et al.
Annales De Dermatologie Et De Venereologie|July 20, 2004
[Relationship between clinical findings of patients with bullous pemphigoid and antigens recognized by their circulating antibasement membrane zone antibodies]A Gary, P Carvalho, J-B Louison, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2023
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life studyK Khelef, E Maubec, G Jeudy, et al.
Annales De Dermatologie Et De Venereologie|April 2, 2019
[Update of the French recommendations for the management of pemphigus]L Jelti, C Prost-Squarcioni, S Ingen-Housz-Oro, et al.
The British Journal of Dermatology|September 6, 2019
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effectD M Chen, A Odueyungbo, E Csinady, et al.
Pageof 10